Reporting Discrepancies May Trigger CMS Sunshine Act Audit

Washington Drug Letter
Drugmakers that face multiple disputes with doctors over payments reported to the Centers for Medicaid & Medicare Services (CMS) under the Physician Payment Sunshine Act will likely face an audit by the agency.

To View This Article:


Buy This Article Now

Add this article to your cart for $25.00